Altered irinotecan metabolism in a patient receiving phenytoin.
about
Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma.Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future.Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
P2860
Altered irinotecan metabolism in a patient receiving phenytoin.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Altered irinotecan metabolism in a patient receiving phenytoin.
@ast
Altered irinotecan metabolism in a patient receiving phenytoin.
@en
type
label
Altered irinotecan metabolism in a patient receiving phenytoin.
@ast
Altered irinotecan metabolism in a patient receiving phenytoin.
@en
prefLabel
Altered irinotecan metabolism in a patient receiving phenytoin.
@ast
Altered irinotecan metabolism in a patient receiving phenytoin.
@en
P2093
P1433
P1476
Altered irinotecan metabolism in a patient receiving phenytoin.
@en
P2093
Allan T van Oosterom
Ernst A de Bruijn
Herlinde Dumez
Ron H J Mathijssen
P304
P356
10.1097/00001813-200202000-00004
P577
2002-02-01T00:00:00Z